SCHEDULE 13D

Company

Oric Pharmaceuticals, Inc.

Filed

May 1, 2020

Accession Number

0000947871-20-000417

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →